BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
-4.07%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$8.61B
AUM Growth
-$1.09B
(-11%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-4.4%
Top 10 Holdings %
Top 10 Hldgs %
30.78%
Holding
207
New
16
Increased
51
Reduced
80
Closed
30
Top Buys
| 1 |
Outset Medical
OM
|
$66.1M |
| 2 |
Boston Scientific
BSX
|
$42.1M |
| 3 |
CareDx
CDNA
|
$31.2M |
| 4 |
Pacific Biosciences
PACB
|
$30.3M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$29.8M |
Top Sells
| 1 |
Biogen
BIIB
|
$106M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$81.3M |
| 3 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$75.3M |
| 4 |
Danaher
DHR
|
$68.9M |
| 5 |
Humana
HUM
|
$68M |
Sector Composition
| 1 | Healthcare | 98.39% |
| 2 | Industrials | 0.69% |
| 3 | Energy | 0.03% |
| 4 | Technology | 0.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Bilibili
BILI
$9.25B
| $19K | ﹤0.01% |
+744
| New | +$19K |
|
177
Pinduoduo
PDD
$177B
| $19K | ﹤0.01% |
+466
| New | +$19K |
|
|
VCRA
178
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| – | – |
-1,160,613
| Closed | -$75.3M |
|
179
Agilent Technologies
A
$36.5B
| – | – |
-1,000
| Closed | -$160K |
|
180
American Express
AXP
$227B
| – | – |
-1,500
| Closed | -$245K |
|
|
CLLS
181
Cellectis
CLLS
$269M
| – | – |
-82,500
| Closed | -$670K |
|
182
Clorox
CLX
$15.5B
| – | – |
-1,200
| Closed | -$209K |
|
183
CyberArk
CYBR
$23.3B
| – | – |
-2,100
| Closed | -$364K |
|
184
Quest Diagnostics
DGX
$20.5B
| – | – |
-15,250
| Closed | -$2.64M |
|
185
Electronic Arts
EA
$42.2B
| – | – |
-2,270
| Closed | -$299K |
|
186
Entegris
ENTG
$12.4B
| – | – |
-3,000
| Closed | -$416K |
|
187
Fortinet
FTNT
$60.4B
| – | – |
-4,015
| Closed | -$289K |
|
188
Graco
GGG
$14.2B
| – | – |
-4,500
| Closed | -$363K |
|
|
IMAB
189
I-MAB
IMAB
$358M
| – | – |
-144,957
| Closed | -$6.87M |
|
190
JD.com
JD
$44.6B
| – | – |
-3,600
| Closed | -$252K |
|
191
Eli Lilly
LLY
$652B
| – | – |
-7,552
| Closed | -$2.09M |
|
192
Live Nation Entertainment
LYV
$37.9B
| – | – |
-4,700
| Closed | -$563K |
|
193
Masimo
MASI
$8B
| – | – |
-131,376
| Closed | -$38.5M |
|
194
Markel Group
MKL
$24.2B
| – | – |
-300
| Closed | -$370K |
|
195
NeoGenomics
NEO
$1.03B
| – | – |
-469,695
| Closed | -$16M |
|
196
Novavax
NVAX
$1.28B
| – | – |
-10,400
| Closed | -$1.49M |
|
197
New York Times
NYT
$9.6B
| – | – |
-7,500
| Closed | -$362K |
|
198
Universal Display
OLED
$6.91B
| – | – |
-1,365
| Closed | -$225K |
|
199
Oscar Health
OSCR
$5.02B
| – | – |
-679,952
| Closed | -$5.34M |
|
200
Spotify
SPOT
$146B
| – | – |
-1,100
| Closed | -$257K |
|